Clinical Efficiency and Safety of Riamilovir for Treating Patients with SARS-CoV-2 Infection

QR Code

Clinical Efficiency and Safety of Riamilovir for Treating Patients with SARS-CoV-2 Infection

Aim. The study evaluates clinical effectiveness and safety of etiotropic antiviral medications with a direct mechanism of action (Riamilovir, Ribavirin, Umifenovir) for the treatment of moderate SARS-CoV-2 infection in adults. Materials and methods. The study used the data from 59 health records of...

Full description

Saved in:

Bibliographic Details
Main Authors:	K. V. Kasyanenko, O. V. Maltsev, K. V. Kozlov, I. I. Lapikov, N. I. Lvov, V. S. Sukachev, K. V. Zhdanov, P. V. Sorokin, A. K. Ratnikova
Format:	Article
Language:	Russian
Published:	LLC "Publishing House OKI" 2021-02-01
Series:	Антибиотики и Химиотерапия
Subjects:	sars-cov-2 new coronavirus disease covid-19 riamilovir nucleoside analogues treatment effectiveness
Online Access:	https://www.antibiotics-chemotherapy.ru/jour/article/view/772
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

New Approaches to Etiotropic Therapy of ARVI Patients with Riamilovir
by: K. V. Zhdanov, et al.
Published: (2024-01-01)

Study of Riamilovir Activity Against SARS-CoV-2 Infection In Syrian Hamsters
by: S. V. Chepur, et al.
Published: (2021-10-01)

Evaluation of the Effectiveness of Riamilovir in Prevention of COVID-19: Mathematical Simulation Results
by: A. S. Sigidaev, et al.
Published: (2025-06-01)

Practical Experience of Using Riamilovir in Treatment of Patients with Moderate COVID-19
by: A. U. Sabitov, et al.
Published: (2020-11-01)

SARS-CoV-2 severity prediction in young adults using artificial intelligence
by: K. V. Kas’janenko, et al.
Published: (2023-01-01)

nucleoside analogues for the treatment of influenza: history and experience
by: K. V. Kasianenko, et al.
Published: (2019-10-01)

The Eﬃcacy and Safety of Riamilovir in the Treatment of Patients with COVID-19
by: А. U. Sabitov, et al.
Published: (2021-05-01)

Meta-analysis of randomized clinical trials of Riamilovir eﬃcacy in etiotropic therapy of inﬂuenza
by: A. U. Sabitov, et al.
Published: (2021-08-01)

Meta-analysis of randomized controlled clinical trials of Riamilovir eﬃcacy in the etiotropic therapy of acute respiratory viral infection
by: A. U. Sabitov, et al.
Published: (2021-08-01)

Clinical efficacy and safety of convalescent plasma therapy for patients with SARS-CoV-2 infection
by: D. V. Lavrenchuk, et al.
Published: (2022-04-01)

Clinical efficacy and safety of nebulized prostacyclin in patients with sARs-CoV-2 (prospective comparative study)
by: K. V. Zhdanov, et al.
Published: (2020-08-01)

Synthesis and Characterization of Some New Nucleoside Analogues from Substituted Benzimidazole via 1,3-Dipolar cycloaddition
by: Baghdad Science Journal
Published: (2016-06-01)

Comparative Effectiveness of Riamilovir and Umifenovir for Treating Influenza
by: A. F. Popov, et al.
Published: (2021-06-01)

Evaluation of the Efficacy of Riamilovir and Oseltamivir Combination on the Experimental Model of Mice Influenza Infection
by: I. N. Falynskova, et al.
Published: (2020-05-01)

The Results of Preclinical Studies Assessing the Effect of Riamilovir on the Reproductive Function and Postnatal Growth of Offspring in Laboratory Animals
by: A. U. Sabitov, et al.
Published: (2023-10-01)

Disinfection of Surfaces Contaminated with SARS-CoV-2 Coronavirus by UV Radiation of Low-Pressure Mercury-Vapour Lamp
by: D. N. Masyakin, et al.
Published: (2023-07-01)

mRNA technology as one of the promising platforms for the SARS-CoV-2 vaccine development
by: A. A. Ilyichev, et al.
Published: (2020-12-01)

On the space of SARS-CoV-2 genetic sequence variants
by: A. Yu. Palyanov, et al.
Published: (2023-12-01)

Nucleoside analogues in treatment of liver cirrhosis as an outcome of chronic hepatitis B
by: I. G. Bakulin
Published: (2009-02-01)

The study of the course of the infectious process in lungs of cats during experimental infection with SARS-CoV-2
by: A. Yu. Filippova, et al.
Published: (2023-11-01)

Case report: thermal helium in the treatment of coronavirus pneumonia caused by new coronavirus infection COVID-19 (SARS-CoV-2)
by: S. V. Zhuravel’, et al.
Published: (2021-04-01)

Herd Immunity to SARS-CoV-2 among the Population in Saint-Petersburg during the COVID-19 Epidemic
by: A. Yu. Popova, et al.
Published: (2020-10-01)

Formation of Herd Immunity to SARS-CoV-2 in the Population of Moscow
by: M A Godkov, et al.
Published: (2022-03-01)

Frequency of SARS-CoV-2 RNA Detection in Foreign Medical Students Vaccined against New Coronavirus Infection
by: O. A. Ryabtseva, et al.
Published: (2023-03-01)

Assessment of the Herd Immunity to SARS-CoV-2 among the Population of the Leningrad Region during the COVID-19 Epidemic
by: A. Yu. Popova, et al.
Published: (2020-10-01)

Production and characterisation of a SARS-CoV-2 S-protein RBD homodimer with increased avidity for specific antibodies
by: A. A. Derkaev, et al.
Published: (2023-04-01)

Eye damage in COVID-19. Part 1: Involvement of the eye in SARS-CoV-2 virus transmission and anterior segment complications
by: N. I. Kurysheva, et al.
Published: (2022-12-01)

by: Westarp, Sarah, et al.
Published: (2025-03-01)

Herd immunity of sars-cov-2 among the population of Kalinigrad region amid the COVID-19 epidemic
by: A. Yu. Popova, et al.
Published: (2021-01-01)

SARS‐CoV‐2: the prospects of the virus spreading and the course of the pathogenesis of coronavirus infection in various species of animals
by: M. S. Fedotova, et al.
Published: (2022-04-01)

Modern modes of chronic hepatitis B treatment in daily clinical practice
by: M. V. Mayevskaya, et al.
Published: (2014-11-01)

Clinical manifestations of asthenic syndrome after coronavirus infection caused by SARS-CoV-2
by: A. O. Mikhailov, et al.
Published: (2023-07-01)

Guidelines for the Management of Patients with Herpetic Keratitis/Keratouveitis in the Long Term: from Problem to Solution
by: G. M. Chernakova, et al.
Published: (2019-12-01)

Efficacy of antiviral therapy in the treatment of severe forms of acute hepatitis B
by: E. V. Esaulenko, et al.
Published: (2016-02-01)

Rapid Emergence and Evolution of SARS-CoV-2 Intrahost Variants among COVID-19 Patients with Prolonged Infections, Singapore
by: Yvonne C.F. Su, et al.
Published: (2025-08-01)

SELECTING THE MANAGEMENT OF PATIENTS WITH CHRONIC HEPATITIS B AFTER THE COMPLETION OF THE LONG-TERM ANTIVIRAL THERAPY
by: E. V. Esaulenko, et al.
Published: (2018-10-01)

Some aspects of specific prevention of a new coronavirus infection caused by the SARS CoV-2 virus in the Samara region
by: A. I. Kiryukhin, et al.
Published: (2023-07-01)

Structural proteins of SARS-CoV-2
by: O. V. Duvanova, et al.
Published: (2023-01-01)

Structure of herd immunity to SARS-COV-2 in the Krasnoyarsk region population in the COVID-19 epidemic
by: A. Yu. Popova, et al.
Published: (2021-08-01)

Assessment of the Viability of SARS-CoV-2 Coronavirus on Various Types of Test Surfaces, as Well as in Drinking and Sea Water
by: V. V. Zolin, et al.
Published: (2021-07-01)